Literature DB >> 22212677

Cancer: Opening the door to a new class of proteasome inhibitors.

Alexandra Flemming.   

Abstract

Entities:  

Year:  2012        PMID： 22212677     DOI： 10.1038/nrd3636

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Inhibition of proteasome deubiquitinating activity as a new cancer therapy.

Authors:  Pádraig D'Arcy; Slavica Brnjic; Maria Hägg Olofsson; Mårten Fryknäs; Kristina Lindsten; Michelandrea De Cesare; Paola Perego; Behnam Sadeghi; Moustapha Hassan; Rolf Larsson; Stig Linder
Journal:  Nat Med       Date:  2011-11-06       Impact factor: 53.440
  1 in total
  1 in total

1.  Up-regulation of RNF187 induces hepatocellular carcinoma cell epithelial to mesenchymal transitions.

Authors:  Song-Lin Yu; Jin-Cai Wu; Peng-Fei Liu; Kai Liu; Chun Ye; Kai-Lun Zhou; Zhuo-Ri Li; Ya-Ping Xu
Journal:  Oncotarget       Date:  2017-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.